欧洲呼吸学会
期刊
会议
图书
作者:Jason Weatherald , Athénaïs Boucly ...
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.52 (4)ERS
摘要:The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk assessment are not well established for systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH).(#br)We assessed incident SSc-PAH patients to determine the associ...
作者:Jason Weatherald , Marie-Camille Chaumais ...
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.50 (1)ERS
摘要:This study aimed to describe the long-term outcomes of pulmonary arterial hypertension (PAH) induced by dasatinib.(#br)21 incident, right heart catheterisation-confirmed cases of dasatinib-induced PAH were identified from the French Pulmonary Hypertension Registry. Clinical ...
作者:Jason Weatherald , Athénaïs Boucly ...
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.50 (3)ERS
摘要:Pulmonary hypertension (PH) is defined by resting mean pulmonary arterial pressure (mPAP) ≥25 mmHg [1]. Patients with pulmonary vascular disease (PVD) or left heart disease (LHD) may demonstrate abnormal haemodynamic responses to exercise even when resting mPAP is normal [2]...
作者:Jason Weatherald , Caroline Sattler ...
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.51 (2)ERS
摘要:The lungs and heart are irrevocably linked in their oxygen (O2) and carbon dioxide (CO2) transport functions. Functional impairment of the lungs often affects heart function and vice versa . The steepness with which ventilation ( V ′E) rises ...
作者:Jason Weatherald , Gérald Simonneau ...
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.50 (4)ERS
摘要:Studies reporting the effects of modern strategies with pulmonary arterial hypertension (PAH)-targeted therapies in sarcoidosis-associated pulmonary hypertension (S-APH) are limited.(#br)Clinical and haemodynamic data from newly diagnosed patients with severe S-APH (mean pul...
作者:Jason Weatherald , Laurent Savale ...
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.50 (2)ERS
摘要:Current European guidelines recommend periodic risk assessment for patients with pulmonary arterial hypertension (PAH). The aim of our study was to determine the association between the number of low-risk criteria achieved within 1 year of diagnosis and long-term prognosis.(...
作者:Marc Humbert , Jason Weatherald
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.52 (1)ERS
摘要:For patients with pulmonary arterial hypertension (PAH), the most recent European guidelines state that right heart catheterisation (RHC) is mandatory for confirming the diagnosis of PAH, and that RHC should be considered 3–6 months after therapy changes and in patients who ...
作者:Jason Weatherald , Marc Humbert
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.51 (3)ERS
摘要:We read with interest the correspondence by M.M. Hoeper and colleagues regarding risk assessment in pulmonary arterial hypertension (PAH). This follows the three manuscripts on the topic published in 2017 in the European Respiratory Journal [1, 2] and in the European Heart Journa...
作者:Jason Weatherald , David Montani ...
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.52 (4)ERS
摘要:The long-term effects of chronic blood exchange transfusions (BETs) on pre-capillary pulmonary hypertension complicating sickle cell disease (SCD) are unknown.(#br)13 homozygous SS SCD patients suffering from pre-capillary pulmonary hypertension and treated by chronic BETs w...
作者:Jason Weatherald , David Montani ...
来源:[J].European Respiratory Review, 2019, Vol.28 (153)ERS
摘要:Pulmonary arterial hypertension (PAH) is a dreaded complication of systemic sclerosis (SSc) that occurs in ∼10% of patients. Most individuals present with severe symptoms, significant functional impairment and severe haemodynamics at diagnosis, and survival after PAH diagnos...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×